瑞康医药：累计回购1.01亿元股份 占总股本2.31%

Core Viewpoint - Ruikang Pharmaceutical has completed its share repurchase plan as of November 6, with a total of 34,638,659 shares repurchased, accounting for 2.31% of the company's total share capital [1] Summary by Relevant Sections - Share Repurchase Details - The repurchase was conducted through centralized bidding transactions [1] - The highest transaction price was 3.08 CNY per share, while the lowest was 2.75 CNY per share [1] - The total amount paid for the repurchase was 101 million CNY [1] - Purpose of Repurchased Shares - The repurchased shares will be used for equity incentives or to implement an employee stock ownership plan [1] - If the shares are not utilized for these purposes within 36 months, the unused portion will be legally canceled [1] - Financial Impact - The share repurchase is not expected to have a significant impact on the company's financials [1] - During the implementation period, relevant parties did not engage in buying or selling the company's stock [1]